中國燃氣(00384.HK)完成發行20億元公司債券
格隆匯10月18日丨中國燃氣(00384.HK)公佈,公司全資子公司中燃投資有限公司2019年面向合格投資者公開發行公司債券(第一期)已於2019年10月18日完成。已發行的中燃投資第一期公司債券的面值總額為人民幣20億元,年期5年,固定票面利率為3.85%,於第三年年末:(a)中燃投資可選擇調整中燃投資第一期公司債券的票面利率;及(b)中燃投資第一期公司債券持有人有權向中燃投資回售中燃投資第一期公司債券。
發行中燃投資第一期公司債券的所得款項扣除發行費用後,將用於償還本集團的到期債券,以及銀行的有息債務。中燃投資第一期公司債券的發行不會額外增加本集團的有息債務總額,有助於進一步優化本集團的債務結構。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.